Jeremy Ruben

SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial

SABR versus standaard radiotherapie bij stadium I NSCLC: CHISEL fase III